ITI Founder & CEO will discuss new developments in cancer immunotherapy October 01, 2018 05:02 PM Eastern Daylight Time ROCKVILLE, Md. (BUSINESSWIRE)--Bill Hearl, Ph.D., Founder and Chief Executive Officer (CEO) ...
Please read the article authored by ITI titled, “The Use and Misuse of Cancer Life Expectancy Statistics” which explores how GBM patients adjust and deal with dire life expectancy statistics. ...
23rd Annual Meeting and Education Day for the Society for Neuro-Oncology, Nov. 15-18, New Orleans, LA
23rd ANNUAL SCIENTIFIC MEETING AND EDUCATION DAY OF THE SOCIETY FOR NEURO-ONCOLOGY Marriott Hotel, New Orleans, Louisiana Thursday, November 15, 8:00am - Sunday, November 18, 1:00pm Click here to view the preliminary ...
The 24th annual BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry. Delegates from all parts of the biotechnology value chain come to BIO-Europe to quickly identify, engage ...
The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables ...
Cohosted by MedImmune, BioHealthInnovation, Wilson Sonsini and JP Morgan this two-day conference will be packed full of investor meetings for local companies looking to raise capital. Contact BHI for more information... ...
Outsourcing in Clinical Trials Mid-Atlantic 2018 October 2nd-3rd 2018, Silver Spring, MD Providing a platform for trial sponsors and solution providers in the Mid-Atlantic region to refine their outsourcing strategy ...
China BioMed Innovation and Investment Conference (CBIIC) was established on November 14, 2016 by China Pharmaceutical Innovation and Research Development Association (PhIRDA), China Association for Medical Devices Industry (CAMDI) and ...
Immunomic Therapeutics Appoints Recognized Immuno-Oncology Expert, Dr. Richard Ambinder, to its Scientific Advisory Board
Immunomic Therapeutics Appoints Recognized Immuno-Oncology Expert, Dr. Richard Ambinder, to its Scientific Advisory Board September 10, 2018 06:00 AM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. (ITI), a privately ...
August is National Immunization Awareness Month, and it provides an excellent opportunity to celebrate how vaccines have greatly reduced disease, disability and death. In 1796, there was one documented successful ...
Glioblastoma topples an American hero, but researchers will continue the fight, article by Dr. Duane Mitchell, University of Florida
Senator McCain fought glioblastoma bravely. Our team, and scientists around the world, remain committed to researching treatment options. Read Dr. Mitchell's article on the progress being made in the treatment ...
